X-Seal EU Post-Market Clinical Follow-Up Protocol

Clinical trial NCT02406612 · COMPLETED

Trial details

NCT number: NCT02406612
Sponsor: Essential Medical, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Femoral Arteriotomy Closure

Start date: 2015-04-01
Primary completion: 2016-02-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.